4.5 Review

Systematic review of the effectiveness of non-pharmacological interventions to improve quality of life of people with dementia

Journal

INTERNATIONAL PSYCHOGERIATRICS
Volume 24, Issue 6, Pages 856-870

Publisher

CAMBRIDGE UNIV PRESS
DOI: 10.1017/S1041610211002614

Keywords

well-being; systematic review; meta-analysis; controlled trial

Funding

  1. NIDA
  2. NIMH
  3. National Institutes of Health, USA
  4. Lundbeck
  5. NHMRC
  6. Australian Commonwealth Department of Health and Ageing
  7. Pfizer
  8. Eisai
  9. Janssen
  10. Novartis
  11. Lilly
  12. Medivation
  13. Sanofi
  14. Prana
  15. NIA
  16. Associated Jewish Federation of Baltimore
  17. Weinberg Foundation
  18. Forest
  19. Glaxo-Smith-Kline
  20. Astra-Zeneca
  21. Ortho-McNeil
  22. Bristol-Myers
  23. National Football League
  24. Elan
  25. Glaxo-Smith Kline
  26. Supernus
  27. Adlyfe
  28. Takeda
  29. Wyeth
  30. Merz
  31. Genentech
  32. NFL Players Association
  33. NFL Benefits Office
  34. Health Monitor
  35. Lilly Lundbeck
  36. Pfizer Eisai

Ask authors/readers for more resources

Background: People with dementia report lower quality of life, but we know little about what interventions might improve it. Methods: We systematically reviewed 20 randomized controlled trials reporting the effectiveness of non-pharmacological interventions in improving quality of life or well-being of people with dementia meeting predetermined criteria. We rated study validity with a checklist. We contacted authors for additional data. We calculated standardized mean differences (SMD) and, for studies reporting similar interventions, pooled standardized effect sizes (SES). Results: Pooled analyses found that family carer coping strategy-based interventions (four studies, which did not individually achieve significance; n=420; SES 0.24 (range 0.03-0.45)) and combined patient activity and family carer coping interventions (two studies, not individually significant; n=191; SES 0.84 (range 0.54-1.14)) might improve quality of life. In one high-quality study, a care management system improved quality of life of people with dementia living at home. Group Cognitive Stimulation Therapy (GCST) improved quality of life of people with dementia in care homes. Conclusion: Preliminary evidence indicated that coping strategy-based family carer therapy with or without a patient activity intervention improved quality of life of people with dementia living at home. GCST was the only effective intervention in a higher quality trial for those in care homes, but we did not find such evidence in the community. Few studies explored whether effects continued after the intervention stopped. Future research should explore the longer-term impact of interventions on, and devise strategies to increase, life quality of people with dementia living in care homes or at home without a family carer.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available